Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes

Current Opinion in Cell Biology

Volumn 17, Issue 2, 2005, Pages 129-134

  Baillie, George S ^a   Houslay, Miles D ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA ARRESTIN; CD28 ANTIGEN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; ISOENZYME; PHOSPHODIESTERASE IV; RETINA S ANTIGEN; T LYMPHOCYTE RECEPTOR;

CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL MEMBRANE; ENZYME SPECIFICITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEART MUSCLE CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

EID: 15044353649     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2005.01.003     Document Type: Review

References (44)

1. J.A. Beavo, and L.L. Brunton Cyclic nucleotide research - still expanding after half a century Nat Rev Mol Cell Biol 3 2002 710 718
2. K. Tasken, and E.M. Aandahl Localized effects of cAMP mediated by distinct routes of protein kinase A Physiol Rev 84 2004 137 167
3. L.L. Brunton, J.S. Hayes, and S.E. Mayer Functional compartmentation of cyclic AMP and protein kinase in heart Adv Cyclic Nucleotide Res 14 1981 391 397
4. M. Zaccolo, and T. Pozzan Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes Science 295 2002 1711 1715
5. J. Zhang, Y. Ma, S.S. Taylor, and R.Y. Tsien Genetically encoded reporters of protein kinase A activity reveal impact of substrate tethering Proc Natl Acad Sci USA 98 2001 14997 15002
6. Y. Nagai, M. Miyazaki, R. Aoki, T. Zama, S. Inouye, K. Hirose, M. Iino, and M. Hagiwara A fluorescent indicator for visualizing cAMP-induced phosphorylation in vivo Nat Biotechnol 18 2000 313 316
7. J.L. Bos EPAC: a new cAMP target and new avenues in cAMP research Nat Rev Mol Cell Biol 4 2003 733 738 This study reviews a new molecule, EPAC, that provides an output, alongside PKA, for cAMP signalling.
8. V.O. Nikolaev, M. Bunemann, L. Hein, A. Hannawacker, and M.J. Lohse Novel single chain cAMP sensors for receptor-induced signal propagation J Biol Chem 279 2004 37215 37218 This study shows how EPACs can be modified to generate a FRET probe for reporting on changes in cAMP in living cells.
9. F. Rochais, G. Vandecasteele, F. Lefebvre, C. Lugnier, H. Lum, J.L. Mazet, D.M. Cooper, and R. Fischmeister Negative feedback exerted by PKA and cAMP phosphodiesterase on subsarcolemmal cAMP signals in Intact cardiac myocytes. An in vivo study using adenovirus-mediated expression of CNG channels J Biol Chem 279 2004 52095 52105 This study provides a demonstration that a cyclic-nucleotide-gated ion channel can be used to report on compartmentalised cAMP changes in cardiac myocytes.
10. J.J. Michel, and J.D. Scott AKAP mediated signal transduction Annu Rev Pharmacol Toxicol 42 2002 235 257
11. S.H. Francis, I.V. Turko, and J.D. Corbin Cyclic nucleotide phosphodiesterases: relating structure and function Prog Nucleic Acid Res Mol Biol 65 2001 1 52
12. D.H. Maurice, D. Palmer, D.G. Tilley, H.A. Dunkerley, S.J. Netherton, D.R. Raymond, H.S. Elbatarny, and S.L. Jimmo Cyclic nucleotide phosphodiesterase activity, expression, and targeting in cells of the cardiovascular system Mol Pharmacol 64 2003 533 546
13. V.C. Manganiello, and E. Degerman Cyclic nucleotide phosphodiesterases (PDEs): diverse regulators of cyclic nucleotide signals and inviting molecular targets for novel therapeutic agents Thromb Haemost 82 1999 407 411
14. M.D. Houslay, and D.R. Adams PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization Biochem J 370 2003 1 18
15. M.D. Houslay PDE4 cAMP-specific phosphodiesterases Prog Nucleic Acid Res Mol Biol 69 2001 249 315
16. M. Conti, W. Richter, C. Mehats, G. Livera, J.Y. Park, and C. Jin Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling J Biol Chem 278 2003 5493 5496
17. M.S. Barnette, and D.C. Underwood New phosphodiesterase inhibitors as therapeutics for the treatment of chronic lung disease Curr Opin Pulm Med 6 2000 164 169
18. D. Spina Phosphodiesterase-4 inhibitors in the treatment of inflammatory lung disease Drugs 63 2003 2575 2594
19. H.T. Zhang, Y. Huang, S.L. Jin, S.A. Frith, N. Suvarna, M. Conti, and J.M. O'Donnell Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme Neuropsychopharmacology 27 2002 587 595
20. S.L. Jin, and M. Conti Induction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responses Proc Natl Acad Sci USA 99 2002 7628 7633
21. C. Mehats, S.L. Jin, J. Wahlstrom, E. Law, D.T. Umetsu, and M. Conti PDE4D plays a critical role in the control of airway smooth muscle contraction FASEB J 17 2003 1831 1841 This targeted gene knockout strategy defines the importance of PDE4D in airway smooth muscle contraction.
22. S.J. MacKenzie, G.S. Baillie, I. McPhee, G.B. Bolger, and M.D. Houslay ERK2 MAP kinase binding, phosphorylation and regulation of PDE4D cAMP specific phosphodiesterases: the involvement of C-terminal docking sites and N-terminal UCR regions J Biol Chem 275 2000 16609 16617
23. R. Hoffmann, G.S. Baillie, S.J. MacKenzie, S.J. Yarwood, and M.D. Houslay The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579 EMBO J 18 1999 893 903
24. H. Liu, D. Palmer, S.L. Jimmo, D.G. Tilley, H.A. Dunkerley, S.C. Pang, and D.H. Maurice Expression of phosphodiesterase 4D (PDE4D) is regulated by both the cyclic AMP-dependent protein kinase and mitogen-activated protein kinase signaling pathways. A potential mechanism allowing for the coordinated regulation of PDE4D activity and expression in cells J Biol Chem 275 2000 26615 26624
25. G. Baillie, S.J. MacKenzie, and M.D. Houslay Phorbol 12-myristate 13-acetate triggers the protein kinase A-mediated phosphorylation and activation of the PDE4D5 cAMP phosphodiesterase in human aortic smooth muscle cells through a route involving extracellular signal regulated kinase (ERK) Mol Pharmacol 60 2001 1100 1111
26. N. Oki, S.I. Takahashi, H. Hidaka, and M. Conti Short term feedback regulation of cAMP in FRTL-5 thyroid cells. Role of pde4d3 phosphodiesterase activation J Biol Chem 275 2000 10831 10837
27. I. McPhee, S.J. Yarwood, E. Huston, G. Scotland, M.B. Beard, A.H. Ross, E.S. Houslay, and M.D. Houslay Association with the src family tyrosyl kinase lyn triggers a conformational change in the catalytic region of human cAMP-specific phosphodiesterase HSPDE4A4B: consequences for rolipram inhibition J Biol Chem 274 1999 11796 11810
28. S.J. Yarwood, M.R. Steele, G. Scotland, M.D. Houslay, and G.B. Bolger The RACK1 signaling scaffold protein selectively interacts with the cAMP-specific phosphodiesterase PDE4D5 isoform J Biol Chem 274 1999 14909 14917
29. G.B. Bolger, A. McCahill, S.J. Yarwood, M.S. Steele, J. Warwicker, and M.D. Houslay Delineation of RAID1, the RACK1 interaction domain located within the unique N-terminal region of the cAMP-specific phosphodiesterase, PDE4D5 BMC Biochem 3 2002 24
30. I. Verde, G. Pahlke, M. Salanova, G. Zhang, S. Wang, D. Coletti, J. Onuffer, S.L. Jin, and M. Conti Myomegalin is a novel protein of the golgi/centrosome that interacts with a cyclic nucleotide phosphodiesterase J Biol Chem 276 2001 11189 11198
31. G.B. Bolger, A.H. Peden, M.R. Steele, C. MacKenzie, D.G. McEwan, D.A. Wallace, E. Huston, G.S. Baillie, and M.D. Houslay Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2 J Biol Chem 278 2003 33351 33363 The first demonstration that specific protein-protein interactions can affect the ability of PKA to phosphorylate a long PDE4 isoform.
32. K.L. Dodge, S. Khouangsathiene, M.S. Kapiloff, R. Mouton, E.V. Hill, M.D. Houslay, L.K. Langeberg, and J.D. Scott mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module EMBO J 20 2001 1921 1930
33. K.A. Tasken, P. Collas, W.A. Kemmner, O. Witczak, M. Conti, and K. Tasken Phosphodiesterase 4D and protein kinase a type II constitute a signaling unit in the centrosomal area J Biol Chem 276 2001 21999 22002
34. 2+- triggered membrane association with selectivity for interaction with phosphatidic acid J Biol Chem 277 2002 28298 28309
35. M. Mongillo, T. McSorley, S. Evellin, A. Sood, V. Lissandron, A. Terrin, E. Huston, A. Hannawacker, M.J. Lohse, and T. Pozzan Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases Circ Res 95 2004 67 75 This study uses a genetically encoded probe to demonstrate the hierarchy of distinct PDE families that underpin cAMP compartmentalisation in cardiac myocytes, in particular the key roles of the PDE3 and PDE4 families.
36. 2-adrenergic stimulation of ICa,L in frog ventricular myocytes J Physiol 551 2003 239 252 This study shows that PDEs have a central role in generating compartmentalised cAMP signalling in myocytes.
37. S.J. Perry, and R.J. Lefkowitz Arresting developments in heptahelical receptor signaling and regulation Trends Cell Biol 12 2002 130 138
38. S.J. Mundell, M.J. Orsini, and J.L. Benovic Characterization of arrestin expression and function Methods Enzymol 343 2002 600 611
39. 2-adrenergic receptors by β-arrestins. Science 2002, 298:834-836.
40. G.B. Bolger, A. McCahill, E. Huston, Y.F. Cheung, T. McSorley, G.S. Baillie, and M.D. Houslay The unique amino-terminal region of the PDE4D5 cAMP phosphodiesterase isoform confers preferential interaction with β-arrestins J Biol Chem 278 2003 49230 49238 The first identification that PDE4D5 is the 'preferred' form to interact with β-arrestin, because of the additional interaction site within its isoform-specific N terminus.
41. i and thence in activation of Erk.
42. R.J. Lefkowitz, K.L. Pierce, and L.M. Luttrell Dancing with different partners: protein kinase a phosphorylation of seven membrane-spanning receptors regulates their G-protein-coupling specificity Mol Pharmacol 62 2002 971 974
43. I.R. Le Jeune, M. Shepherd, G. Van Heeke, M.D. Houslay, and I.P. Hall Cyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells. Identification and characterization of a novel PDE4D5 promoter J Biol Chem 277 2002 35980 35989
44. H. Abrahamsen, G. Baillie, J. Ngai, T. Vang, K. Nika, A. Ruppelt, T. Mustelin, M. Zaccolo, M. Houslay, and K. Tasken TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling J Immunol 173 2004 4847 4858 This study is the first to find that ligation of the TCR and CD28 can cause the recruitment of both β-arrestin and PDE4 isoforms to lipid rafts. This gives key, novel insight into a means whereby CD28 serves to augment T-cell activation upon liganding of the TCR by recruiting PDE4, which acts to lower (localised) cAMP levels, thereby attenuating the inhibitory action of AKAP-anchored PKA exerted through the Csk.